CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference38 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005
2. CYP2D6 and tamoxifen: DNA matters in breast cancer;Hoskins;Nat Rev Cancer,2009
3. CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8;Goetz;Clin Cancer Res,2013
4. Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients;Kiyotani;J Clin Oncol,2010
5. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen;Schroth;J Am Med Assoc,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment for Resistant Hypertension Under the Guidance of Pharmacogenomics: A Randomised Controlled Open-Label Trial;Journal of the College of Physicians and Surgeons Pakistan;2024-04-01
2. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China;Open Life Sciences;2024-01-01
3. Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation;Oncology Research;2024
4. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
5. Omics Sciences in Drug Discovery, Safety, and Pharmacokinetics;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3